1. Administration, U. D. o. H. a. H. S. F. a. D. (2009). Guidance for Industry: Patient-reported outcome measures: use in medical product development to support labeling claims. Silver Spring, US Food and Drug Administration.
2. Juniper, E. F., Guyatt, G. H., Ferrie, P. J., & Griffith, L. E. (1993). Measuring Quality of Life in Asthma. American Review of Respiratory Disease, 147, 832-838, doi:https://10.1164/ajrccm/147.4.832.
3. Juniper, E. F., Guyatt, G. H., Epstein, R. S., Ferrie, P. J., Jaeschke, R., & Hiller, T. K. (1992). Evaluation of impairment of health related quality of life in asthma: Development of a questionnaire for use in clinical trials. Thorax, 47, 76-83, doi:https://10.1136/thx.47.2.76.
4. Marks, G. B., Dunn, S. M., & Woolcock, A. J. (1992). A scale for the measurement of quality of life in adults with asthma. Journal of clinical epidemiology, 45(5), 461-472, doi:https://doi.org/10.1016/0895-4356(92)90095-5.
5. Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992). A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory Questionnaire. American Review of Respiratory Disease, 145, 1321-1327, doi:https://10.1164/ajrccm/145.6.1321.
6. Hyland, M. E., Bellesis, M., Thompson, P. J., & Paul Kenyon, C. A. (1996). The constructs of asthma quality of life: Psychometric, experimental and correlational evidence. Psychology & Health, 12(1), 101-121, doi:10.1080/08870449608406925.
7. Hyland, M. E., Lanario, J. W., Pooler, J., Masoli, M., & Jones, R. C. (2018). How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma. Health and Quality of Life Outcomes, 16, 1-9, doi:https://10.1186/s12955-018-0851-9.
8. Hyland, M. E., Jones, R. C., Lanario, J. W., & Masoli, M. (2018). The construction and validation of the Severe Asthma Questionnaire. Eur Respir J, 52(1), doi:https://10.1183/13993003.00618-2018.
9. Hyland, M. E., Whalley, B., Jones, R. C., & Masoli, M. (2015). A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales. Qual Life Res, 24(3), 631-639, doi:https://10.1007/s11136-014-0801-x.
10. Foster, J. M., McDonald, V. M., Guo, M., & Reddel, H. K. (2017). "I have lost in every facet of my life": the hidden burden of severe asthma. Eur Respir J, 50(3), doi:https://10.1183/13993003.00765-2017.
11. Eassey, D., Reddel, H. K., Foster, J. M., Kirkpatrick, S., Locock, L., Ryan, K., et al. (2018). "...I've said I wish I was dead, you'd be better off without me": A systematic review of people's experiences of living with severe asthma. J Asthma, 1-12, doi:https://10.1080/02770903.2018.1452034.
12. Holguin, F., Cardet, J. C., Chung, K. F., Diver, S., Ferreira, D. S., Fitzpatrick, A., et al. (2020). Management of severe asthma: A European Respiratory Society/American Thoracic Society guideline. [Article]. European Respiratory Journal, 55(1), doi:https://10.1183/13993003.00588-2019.
13. Hyland, M. E., & Sodergren, S. C. (1996). Development of a new type of global quality of life scale, and comparison of performance and preference for 12 global scales. Quality of Life Research, 5(5), 469-480.
14. Nathan, R. A., Sorkness, C. A., Kosinski, M., Schatz, M., Li, J. T., Marcus, P., et al. (2004). Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol, 113(1), 59-65, doi:https://10.1016/j.jaci.2003.09.008.
15. Juniper, E. F., Bousquet, J., Abetz, L., Bateman, E. D., & Committee, G. (2006). Identifying ‘well-controlled’and ‘not well-controlled’asthma using the Asthma Control Questionnaire. Respiratory Medicine, 100(4), 616-621, doi:https://doi.org/10.1016/j.rmed.2005.08.012.
16. Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20, 1727-1736, doi:https://10.1007/s11136-011-9903-x.
17. Devlin, N. J., Shah, K. K., Feng, Y., Mulhern, B., & van Hout, B. (2018). Valuing health‐related quality of life: An EQ‐5 D‐5 L value set for E ngland. Health economics, 27(1), 7-22.
18. Global Initiative for Asthma (2019). GINA Report, Global Strategy for Asthma Management and Prevention.
19. Osborne, J. (2014). Best practices in exploratory factor analysis. Louisville, NY: CreateSpace Independent Publishing Platform.
20. Costello, A. B., & Osborne, J. (2005). Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis. Practical assessment, research, and evaluation, 10(1), 7.
21. Kaiser, H. F. (1991). Coefficient Alpha for a Principal Component and the Kaiser-Guttman Rule. Psychological Reports, 68(3), 855-858, doi:https://10.2466/pr0.1991.68.3.855.
22. McCrae, R. R., & Costa, P. T. (1987). Validation of the five-factor model of personality across instruments and observers. Journal of Personality and Social Psychology, 52(1), 81-90, doi:https://10.1037/0022-3514.52.1.81.
23. Hyland, M. E., Jeffery, A. N., & Wilkin, T. J. (2014). A biological, latent variable model of health (EarlyBird 68). Brain, behavior, and immunity, 40, 104-109, doi:https://doi.org/10.1016/j.bbi.2014.02.018.
24. Hyland, M. E. (1992). A reformulation of quality of life for medical science. Quality of Life Research, 1;1, 267-272, doi:https://doi.org/10.1007/bf00435636.
25. Lanario, J. W., Hyland, M. E., Wei, Y., Jones, R. C., & Masoli, M. (2020). Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma. Respiratory Medicine, 105870, doi:https://doi.org/10.1016/j.rmed.2020.105870.
26. Oga, T., Nishimura, K., Tsukino, M., Sato, S., Hajiro, T., & Mishima, M. (2002). Comparison of the responsiveness of different disease-specific health status measures in patients with asthma. Chest, 122(4), 1228-1233, doi:https://doi.org/10.1378/chest.122.4.1228.